DCM
CLVS

Dupont Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Dupont Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-102,527
Closed -$207K – 1869
2022
Q1 		$207K Buy
+102,527
New +$201K 0.01% 1043
2021
Q3 		– Sell
-69,101
Closed -$401K – 1914
2021
Q2 		$401K Buy
69,101
+32,680
+90% +$191K 0.01% 1090
2021
Q1 		$256K Sell
36,421
-7,470
-17% -$50.1K 0.01% 1197
2020
Q4 		$211K Sell
43,891
-3,276
-7% -$16.6K ﹤0.01% 1128
2020
Q3 		$275K Buy
47,167
+17,230
+58% +$103K 0.01% 1007
2020
Q2 		$202K Sell
29,937
-2,673
-8% -$20.2K ﹤0.01% 1123
2020
Q1 		$207K Hold
32,610
– – ﹤0.01% 1012
2019
Q4 		$340K Buy
+32,610
New +$237K 0.01% 1024
2016
Q1 		– Sell
-6,703
Closed -$235K – 715
2015
Q4 		$235K Hold
6,703
– – 0.01% 626
2015
Q3 		$616K Hold
6,703
– – 0.02% 505
2015
Q2 		$589K Hold
6,703
– – 0.01% 497
2015
Q1 		$498K Hold
6,703
– – 0.01% 510
2014
Q4 		$375K Hold
6,703
– – 0.01% 570
2014
Q3 		$304K Buy
6,703
+930
+16% +$38.9K 0.01% 605
2014
Q2 		$239K Hold
5,773
– – ﹤0.01% 620
2014
Q1 		$400K Hold
5,773
– – 0.01% 596
2013
Q4 		$348K Sell
5,773
-894
-13% -$48.6K 0.01% 577
2013
Q3 		$405K Hold
6,667
– – 0.01% 567
2013
Q2 		$447K Buy
+6,667
New +$300K 0.01% 547

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Dupont Capital Management's CLVS Position: Q2 2022 in Review

Dupont Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 102,527 shares — an estimated $207K sold.

Dupont Capital Management first reported a position in CLVS in Q2 2013 and held it in 19 quarters. The position peaked at $616K in Q3 2015. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Dupont Capital Management reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Dupont Capital Management sold 102,527 Clovis Oncology, Inc. shares in Q2 2022, an estimated $207K.
  • Dupont Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 19 quarters.
  • Dupont Capital Management's Clovis Oncology, Inc. position peaked at $616K in Q3 2015.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.